Fig. 3From: Multicenter retrospective study on the use of Curebest™ 95GC Breast for estrogen receptor-positive and node-negative early breast cancerRelapse-free survival curves for PAM50 Luminal B for each result of 95GC. Relapse-free survival was evaluated in patients with luminal B tumors in the 95GC-L group (in blue) and 95GC-H group (in red) for up to 120 months post-surgery. The log-rank test was used to evaluate statistical differencesBack to article page